(4-((1-(tert-Butoxycarbonyl)piperidin-4-yl)oxy)-3-methoxyphenyl)boronic acid

Catalog No.: 
ACBDUA189
CAS No.: 
1072946-30-5
Molecular Formula: 
C17H26BNO6
Molecular Weight: 
351.21
(4-((1-(tert-Butoxycarbonyl)piperidin-4-yl)oxy)-3-methoxyphenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$619.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-((1-(tert-Butoxycarbonyl)piperidin-4-yl)oxy)-3-methoxyphenyl)boronic acid
IUPAC Name(4-((1-(tert-butoxycarbonyl)piperidin-4-yl)oxy)-3-methoxyphenyl)boronic acid
MDL No.MFCD10699636
Molecular FormulaC17H26BNO6
Molecular Weight351.21
SMILESCOC1=CC(B(O)O)=CC=C1OC2CCN(C(OC(C)(C)C)=O)CC2
InChI KeyQSRZLYBVNHMVDO-UHFFFAOYSA-N
Synonym1-Piperidinecarboxylic acid, 4-(4-borono-2-methoxyphenoxy)-, 1-(1,1-dimethylethyl) ester
CAS No.1072946-30-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBDUA189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXOZ718 route compound structure diagram
    ACFXOZ718182344-21-4In Stock
  4. Then
  5. ACBDUA189 route product structure diagram
    ACBDUA1891072946-30-5
Inquiry

2. ACBDUA189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBDUA189 route product structure diagram
    ACBDUA1891072946-30-5
Inquiry

3. ACBDUA189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBDUA189 route product structure diagram
    ACBDUA1891072946-30-5
Inquiry

Comments (0)